Diabetes Care
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by von Eynatten, M.
Right arrow Articles by Dugi, K. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by von Eynatten, M.
Right arrow Articles by Dugi, K. A.
Social Bookmarking
Add to CiteULike   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?
Diabetes Care 28:754-755, 2005
© 2005 by the American Diabetes Association, Inc.

Letters: Observations

Adipocytokines as a Novel Target for the Anti-inflammatory Effect of Atorvastatin in Patients With Type 2 Diabetes

Maximilian von Eynatten, MD, Jochen G. Schneider, MD, Senad Hadziselimovic, MD, Andreas Hamann, MD, Angelika Bierhaus, PHD, Peter P. Nawroth, MD and Klaus A. Dugi, MD

From the Department of Endocrinology and Metabolism, Ruprecht-Karls-University of Heidelberg, Heidelberg, Germany

Address correspondence to Maximilian von Eynatten, Department of Medicine I, University of Heidelberg, INF 410, D-69120 Heidelberg, Germany. E-mail: maximilian.eynatten@med.uni-heidelberg.de

The first 20% of the full text of this article appears below.

Recently, Shetty et al. (1) reported a positive correlation of resistin with C-reactive protein (CRP) in a cross-sectional study of patients with type 1 or type 2 diabetes and patients in a pre-diabetic state. Collectively, however, little is known about the role of proinflammatory adipocytokines. The adipocyte-secreted hormones leptin and resistin have recently been regarded as pro-inflammatory cytokines positively associated with CRP in healthy subjects (2) and patients with diabetes (1). Shetty et al. therefore investigated whether atorvastatin may mediate part of its beneficial effects by altering resistin levels. They did find a 20% reduction of plasma resistin after statin treatment. Due to a concomitant decrease . . . [Full Text of this Article]


Add to CiteULike CiteULike   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
 Cardiovasc ResHome page
J. Herrmann
Large meals and large arteries: Is resistin the link?
Cardiovasc Res, January 1, 2006; 69(1): 9 - 12.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Diabetes Diabetes Care Clinical Diabetes Diabetes Spectrum
Copyright © 2005 by the American Diabetes Association.